| 0 (0%) | 12-05 10:03 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.18 | 1-year : | 6.05 |
| Resists | First : | 4.44 | Second : | 5.18 |
| Pivot price | 3.98  |
|||
| Supports | First : | 3.46  |
Second : | 2.86 |
| MAs | MA(5) : | 4.03 |
MA(20) : | 4 |
| MA(100) : | 2.71 |
MA(250) : | 0 | |
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 70.6 |
D(3) : | 68.6 |
| RSI | RSI(14): 60.5 |
|||
| 52-week | High : | 4.44 | Low : | 0.75 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ APYX ] has closed below upper band by 30.2%. Bollinger Bands are 64.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.16 - 4.18 | 4.18 - 4.2 |
| Low: | 3.91 - 3.93 | 3.93 - 3.95 |
| Close: | 3.99 - 4.03 | 4.03 - 4.06 |
Wed, 03 Dec 2025
Apyx Medical announces approval, commercial launch of Apyx One console - TipRanks
Wed, 03 Dec 2025
Apyx Medical Corporation announces approval and commercial launch of Apyx One console and single-use handpieces - marketscreener.com
Wed, 03 Dec 2025
Apyx Medical launches Apyx One console in South Korea - Investing.com
Wed, 03 Dec 2025
Apyx Medical Corporation Announces Approval and Commercial - GlobeNewswire
Tue, 18 Nov 2025
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 41 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 13.4 (%) |
| Held by Institutions | 38.3 (%) |
| Shares Short | 280 (K) |
| Shares Short P.Month | 313 (K) |
| EPS | -0.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.15 |
| Profit Margin | -30.4 % |
| Operating Margin | -6.5 % |
| Return on Assets (ttm) | -10.1 % |
| Return on Equity (ttm) | -168.2 % |
| Qtrly Rev. Growth | 12.1 % |
| Gross Profit (p.s.) | 0.73 |
| Sales Per Share | 1.16 |
| EBITDA (p.s.) | -0.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -8 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -11.23 |
| PEG Ratio | 0 |
| Price to Book value | 25.25 |
| Price to Sales | 3.45 |
| Price to Cash Flow | -19.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|